Prescription For Failure: Why Trump’s Drug Plan Is Bad w/ Yale Economist Jason Abaluck
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Prescription For Failure: Why Trump’s Drug Plan Is Bad w/ Yale Economist Jason Abaluck
-
ナレーター：
-
著者：
このコンテンツについて
Send us a text
Two weeks after Donald Trump announced he was going to lower drug prices from anywhere from 30% to 90%, there still haven't been any deals made.
But more than that, what he wants to do, something called Most Favored Nation status, is bad policy, especially when it comes to drug prices.
Grant is joined by Yale Economist Jason Abaluck to talk about why Trump's plan to lower drug prices won't lower them, might raise prices, could stifle medical innovation at home and abroad, and what that means for your next prescription.
LINKS:
Jason Abaluck's Research
Support the show
Follow along on social media
X: @mimsnewspod
Instagram: @mimsnewspod
TikTok: @mimsnewspod
Substack: mimsnewspod.substack.com
YouTube: youtube.com/@MIMSnewspod
Bluesky: Granthermes.bsky.social
Follow Grant:
X: @GrantHermes
Insta/TikTok: GrantHermesTV